Vimarsana
Biggest News Aggregation in the World

Page 11 - Imaging Tests News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imaging Tests. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imaging Tests Today - Breaking & Trending Today

Skin Cancer Diagnostics Market Size Worth $5.48Bn, Globally, by 2028 at 7.2% CAGR - Exclusive Report by The Insight Partners - Vimarsana News

Skin Cancer Diagnostics Market Size Worth $5.48Bn, Globally, by 2028 at 7.2% CAGR - Exclusive Report by The Insight Partners

/PRNewswire/ -- The Insight Partners published latest research study on "Skin Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis...

The Worldwide Liver Cancer Diagnostics Industry is Expected to Reach $17.4 Billion by 2028 - Vimarsana News

The Worldwide Liver Cancer Diagnostics Industry is Expected to Reach $17.4 Billion by 2028

/PRNewswire/ -- The "Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Type (Laboratory Tests, Imaging Tests, Endoscopy, Biopsy), by...

Global Liver Cancer Diagnostics Market (2021 to 2028) - Size, Share & Trends Analysis Report - Vimarsana News

Global Liver Cancer Diagnostics Market (2021 to 2028) - Size, Share & Trends Analysis Report

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Global Respiratory Disease Testing Industry to Gain $20.1 - Vimarsana News

Global Respiratory Disease Testing Industry to Gain $20.1

The global respiratory disease testing market is projected to upsurge during the coronavirus pandemic due to rise in the respiratory diseases. The key...

Global Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Analysis - Vimarsana News

Global Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Analysis

Share: ResearchAndMarkets.com's offering. The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.80% from 2020 to 2028. Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are the factors driving the global irritable bowel syndrome (IBS) diagnostics market. However, the challenges in diagnosis of IBS are hindering the market growth. Irritable bowel syndrome (IBS) is defined...